« Previous
Next »
Gastrointestinal Endoscopy
Volume 71, Issue 4
, Pages 694-696
, April 2010
Cryotherapy for the prevention and treatment of esophageal cancer: when does efficacy equal success?
References
- Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249
- An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus. Endoscopy. 2009;41:400–408
- Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126–1132
- Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277–2288
- Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc. 2010;71:686–693
- Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc. 2010;71:680–685
- A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology. 2009;136:2101–2114
- Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus. Gastrointest Endosc. 2010;71:697–703
- Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci. Int J Cancer. 2006;118:155–160
- . Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy. 2008;40:1008–1015
PII: S0016-5107(10)00198-7
doi: 10.1016/j.gie.2010.02.026
© 2010 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastrointestinal Endoscopy
Volume 71, Issue 4
, Pages 694-696
, April 2010
